Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Methodology

A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences

Authors: Matthew J Gurka, Christa L Ice, Shumei S Sun, Mark D DeBoer

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Objective

The metabolic syndrome (MetS) is a cluster of clinical indices that signals increased risk for cardiovascular disease and Type 2 diabetes. The diagnosis of MetS is typically based on cut-off points for various components, e.g. waist circumference and blood pressure. Because current MetS criteria result in racial/ethnic discrepancies, our goal was to use confirmatory factor analysis to delineate differential contributions to MetS by sub-group.

Research Design and Methods

Using 1999–2010 data from the National Health and Nutrition Examination Survey (NHANES), we performed a confirmatory factor analysis of a single MetS factor that allowed differential loadings across sex and race/ethnicity, resulting in a continuous MetS risk score that is sex and race/ethnicity-specific.

Results

Loadings to the MetS score differed by racial/ethnic and gender subgroup with respect to triglycerides and HDL-cholesterol. ROC-curve analysis revealed high area-under-the-curve concordance with MetS by traditional criteria (0.96), and with elevations in MetS-associated risk markers, including high-sensitivity C-reactive protein (0.71), uric acid (0.75) and fasting insulin (0.82). Using a cut off for this score derived from ROC-curve analysis, the MetS risk score exhibited increased sensitivity for predicting elevations in ≥2 of these risk markers as compared with traditional pediatric MetS criteria.

Conclusions

The equations from this sex- and race/ethnicity-specific analysis provide a clinically-accessible and interpretable continuous measure of MetS that can be used to identify children at higher risk for developing adult diseases related to MetS, who could then be targeted for intervention. These equations also provide a powerful new outcome for use in childhood obesity and MetS research.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shen BJ, Todaro JF, Niaura R, McCaffery JM, Zhang J, Spiro A, Ward KD: Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol. 2003, 157 (8): 701-711. 10.1093/aje/kwg045.CrossRefPubMed Shen BJ, Todaro JF, Niaura R, McCaffery JM, Zhang J, Spiro A, Ward KD: Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol. 2003, 157 (8): 701-711. 10.1093/aje/kwg045.CrossRefPubMed
2.
go back to reference Tenenbaum A, Fisman EZ: “The metabolic syndrome. is dead”: these reports are an exaggeration. Cardiovasc Diabetol. 2011, 10 (1): 11-10.1186/1475-2840-10-11.PubMedCentralCrossRefPubMed Tenenbaum A, Fisman EZ: “The metabolic syndrome. is dead”: these reports are an exaggeration. Cardiovasc Diabetol. 2011, 10 (1): 11-10.1186/1475-2840-10-11.PubMedCentralCrossRefPubMed
3.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al: Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005, 112 (17): 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al: Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005, 112 (17): 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
4.
go back to reference Lawlor DA, Ebrahim S, May M, Davey Smith G: (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol. 2004, 159 (11): 1013-1018. 10.1093/aje/kwh150.CrossRefPubMed Lawlor DA, Ebrahim S, May M, Davey Smith G: (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol. 2004, 159 (11): 1013-1018. 10.1093/aje/kwh150.CrossRefPubMed
5.
go back to reference Li C, Ford ES: Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care. 2007, 30 (6): 1556-1561. 10.2337/dc06-2481.CrossRefPubMed Li C, Ford ES: Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care. 2007, 30 (6): 1556-1561. 10.2337/dc06-2481.CrossRefPubMed
6.
go back to reference Martinez-Vizcaino V, Martinez MS, Aguilar FS, Martinez SS, Gutierrez RF, Lopez MS, Martinez PM, Rodriguez-Artalejo F: Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care. 2010, 33 (6): 1370-1372. 10.2337/dc09-2049.PubMedCentralCrossRefPubMed Martinez-Vizcaino V, Martinez MS, Aguilar FS, Martinez SS, Gutierrez RF, Lopez MS, Martinez PM, Rodriguez-Artalejo F: Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care. 2010, 33 (6): 1370-1372. 10.2337/dc09-2049.PubMedCentralCrossRefPubMed
7.
go back to reference Ford ES, Li C, Cook S, Choi HK: Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007, 115 (19): 2526-2532. 10.1161/CIRCULATIONAHA.106.657627.CrossRefPubMed Ford ES, Li C, Cook S, Choi HK: Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007, 115 (19): 2526-2532. 10.1161/CIRCULATIONAHA.106.657627.CrossRefPubMed
8.
go back to reference Morrison JA, Friedman LA, Wang P, Glueck CJ: Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008, 152 (2): 201-206. 10.1016/j.jpeds.2007.09.010.CrossRefPubMed Morrison JA, Friedman LA, Wang P, Glueck CJ: Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008, 152 (2): 201-206. 10.1016/j.jpeds.2007.09.010.CrossRefPubMed
9.
go back to reference Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S: The metabolic syndrome in children and adolescents. Lancet. 2007, 369 (9579): 2059-2061. 10.1016/S0140-6736(07)60958-1.CrossRefPubMed Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S: The metabolic syndrome in children and adolescents. Lancet. 2007, 369 (9579): 2059-2061. 10.1016/S0140-6736(07)60958-1.CrossRefPubMed
10.
go back to reference Ford ES, Ajani UA, Mokdad AH: The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care. 2005, 28 (4): 878-881. 10.2337/diacare.28.4.878.CrossRefPubMed Ford ES, Ajani UA, Mokdad AH: The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care. 2005, 28 (4): 878-881. 10.2337/diacare.28.4.878.CrossRefPubMed
11.
go back to reference Gagliardi AC, Miname MH, Santos RD: Uric acid: A marker of increased cardiovascular risk. Atherosclerosis. 2009, 202 (1): 11-17. 10.1016/j.atherosclerosis.2008.05.022.CrossRefPubMed Gagliardi AC, Miname MH, Santos RD: Uric acid: A marker of increased cardiovascular risk. Atherosclerosis. 2009, 202 (1): 11-17. 10.1016/j.atherosclerosis.2008.05.022.CrossRefPubMed
12.
go back to reference Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C: Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. 2012, 41 (3): 450-457. 10.1007/s12020-012-9629-8.CrossRefPubMed Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C: Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. 2012, 41 (3): 450-457. 10.1007/s12020-012-9629-8.CrossRefPubMed
13.
go back to reference Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC: Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol. 2000, 151 (2): 190-198. 10.1093/oxfordjournals.aje.a010187.CrossRefPubMed Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC: Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol. 2000, 151 (2): 190-198. 10.1093/oxfordjournals.aje.a010187.CrossRefPubMed
14.
go back to reference DeBoer MD, Dong L, Gurka MJ: Racial/Ethnic and sex differences in the ability of metabolic syndrome criteria to predict elevations in fasting insulin levels in adolescents. J Pediatr. 2011, 159 (6): 975-981. 10.1016/j.jpeds.2011.05.023. e973PubMedCentralCrossRefPubMed DeBoer MD, Dong L, Gurka MJ: Racial/Ethnic and sex differences in the ability of metabolic syndrome criteria to predict elevations in fasting insulin levels in adolescents. J Pediatr. 2011, 159 (6): 975-981. 10.1016/j.jpeds.2011.05.023. e973PubMedCentralCrossRefPubMed
15.
go back to reference Sung KC, Seo MH, Rhee EJ, Wilson AM: Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study. Cardiovasc Diabetol. 2011, 10: 108-10.1186/1475-2840-10-108.PubMedCentralCrossRefPubMed Sung KC, Seo MH, Rhee EJ, Wilson AM: Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study. Cardiovasc Diabetol. 2011, 10: 108-10.1186/1475-2840-10-108.PubMedCentralCrossRefPubMed
16.
go back to reference Martinez-Vizcaino V, Ortega FB, Solera-Martinez M, Ruiz JR, Labayen I, Eensoo D, Harro J, Loit HM, Veidebaum T, Sjostrom M: Stability of the factorial structure of metabolic syndrome from childhood to adolescence: a 6-year follow-up study. Cardiovasc Diabetol. 2011, 10: 81-10.1186/1475-2840-10-81.PubMedCentralCrossRefPubMed Martinez-Vizcaino V, Ortega FB, Solera-Martinez M, Ruiz JR, Labayen I, Eensoo D, Harro J, Loit HM, Veidebaum T, Sjostrom M: Stability of the factorial structure of metabolic syndrome from childhood to adolescence: a 6-year follow-up study. Cardiovasc Diabetol. 2011, 10: 81-10.1186/1475-2840-10-81.PubMedCentralCrossRefPubMed
17.
go back to reference Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation. 2005, 112 (5): 666-673. 10.1161/CIRCULATIONAHA.104.516948.CrossRefPubMed Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation. 2005, 112 (5): 666-673. 10.1161/CIRCULATIONAHA.104.516948.CrossRefPubMed
18.
go back to reference Hanley AJ, Karter AJ, Williams K, Festa A, D’Agostino RB, Wagenknecht LE, Haffner SM: Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the insulin resistance atherosclerosis study. Circulation. 2005, 112 (24): 3713-3721. 10.1161/CIRCULATIONAHA.105.559633.CrossRefPubMed Hanley AJ, Karter AJ, Williams K, Festa A, D’Agostino RB, Wagenknecht LE, Haffner SM: Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the insulin resistance atherosclerosis study. Circulation. 2005, 112 (24): 3713-3721. 10.1161/CIRCULATIONAHA.105.559633.CrossRefPubMed
19.
go back to reference van Vliet M, Heymans MW, von Rosenstiel IA, Brandjes DP, Beijnen JH, Diamant M: Cardiometabolic risk variables in overweight and obese children: a worldwide comparison. Cardiovasc Diabetol. 2011, 10: 106-10.1186/1475-2840-10-106.PubMedCentralCrossRefPubMed van Vliet M, Heymans MW, von Rosenstiel IA, Brandjes DP, Beijnen JH, Diamant M: Cardiometabolic risk variables in overweight and obese children: a worldwide comparison. Cardiovasc Diabetol. 2011, 10: 106-10.1186/1475-2840-10-106.PubMedCentralCrossRefPubMed
20.
go back to reference DeBoer MD: Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions. Nutrition. 2012, 10.1016/j.nut.2012.07.003. DeBoer MD: Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions. Nutrition. 2012, 10.1016/j.nut.2012.07.003.
21.
go back to reference de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N: Prevalence of the metabolic syndrome in American adolescents: findings from the third national health and nutrition examination survey. Circulation. 2004, 110 (16): 2494-2497. 10.1161/01.CIR.0000145117.40114.C7.CrossRefPubMed de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N: Prevalence of the metabolic syndrome in American adolescents: findings from the third national health and nutrition examination survey. Circulation. 2004, 110 (16): 2494-2497. 10.1161/01.CIR.0000145117.40114.C7.CrossRefPubMed
22.
go back to reference DeBoer MD, Gurka MJ: Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999–2006. Metab Syndr Relat Disord. 2010, 8 (4): 343-353. 10.1089/met.2010.0008.PubMedCentralCrossRefPubMed DeBoer MD, Gurka MJ: Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999–2006. Metab Syndr Relat Disord. 2010, 8 (4): 343-353. 10.1089/met.2010.0008.PubMedCentralCrossRefPubMed
23.
go back to reference Lee S, Bacha F, Gungor N, Arslanian S: Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr. 2008, 152 (2): 177-184. 10.1016/j.jpeds.2007.07.053.CrossRefPubMed Lee S, Bacha F, Gungor N, Arslanian S: Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr. 2008, 152 (2): 177-184. 10.1016/j.jpeds.2007.07.053.CrossRefPubMed
24.
go back to reference Reinehr T, de Sousa G, Toschke AM, Andler W: Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child. 2007, 92 (12): 1067-1072. 10.1136/adc.2006.104588.PubMedCentralCrossRefPubMed Reinehr T, de Sousa G, Toschke AM, Andler W: Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child. 2007, 92 (12): 1067-1072. 10.1136/adc.2006.104588.PubMedCentralCrossRefPubMed
25.
go back to reference Sumner AE: Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J Pediatr. 2009, 155 (3): e7-11. S7CrossRefPubMed Sumner AE: Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J Pediatr. 2009, 155 (3): e7-11. S7CrossRefPubMed
26.
go back to reference Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994. Arch Intern Med. 2003, 163 (4): 427-436. 10.1001/archinte.163.4.427.PubMedCentralCrossRefPubMed Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994. Arch Intern Med. 2003, 163 (4): 427-436. 10.1001/archinte.163.4.427.PubMedCentralCrossRefPubMed
27.
go back to reference Walker SE, Gurka MJ, Oliver MN, Johns DW, Deboer MD: Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr Metab Cardiovasc Dis. 2012, 22 (2): 141-148. 10.1016/j.numecd.2010.05.006.PubMedCentralCrossRefPubMed Walker SE, Gurka MJ, Oliver MN, Johns DW, Deboer MD: Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr Metab Cardiovasc Dis. 2012, 22 (2): 141-148. 10.1016/j.numecd.2010.05.006.PubMedCentralCrossRefPubMed
28.
go back to reference Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB: State of disparities in cardiovascular health in the United States. Circulation. 2005, 111 (10): 1233-1241. 10.1161/01.CIR.0000158136.76824.04.CrossRefPubMed Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB: State of disparities in cardiovascular health in the United States. Circulation. 2005, 111 (10): 1233-1241. 10.1161/01.CIR.0000158136.76824.04.CrossRefPubMed
29.
go back to reference DeBoer MD, Gurka MJ, Sumner AE: Diagnosis of the metabolic syndrome is associated with disproportionately high levels of high-sensitivity C-reactive protein in Non-Hispanic black adolescents: an analysis of NHANES 1999–2008. Diabetes Care. 2011, 34 (3): 734-740. 10.2337/dc10-1877.PubMedCentralCrossRefPubMed DeBoer MD, Gurka MJ, Sumner AE: Diagnosis of the metabolic syndrome is associated with disproportionately high levels of high-sensitivity C-reactive protein in Non-Hispanic black adolescents: an analysis of NHANES 1999–2008. Diabetes Care. 2011, 34 (3): 734-740. 10.2337/dc10-1877.PubMedCentralCrossRefPubMed
30.
go back to reference DeBoer MD, Gurka MJ: Low sensitivity for the metabolic syndrome to detect uric acid elevations in females and non-Hispanic-black male adolescents: An analysis of NHANES 1999–2006. Atherosclerosis. 2012, 220 (2): 575-580. 10.1016/j.atherosclerosis.2011.11.033.PubMedCentralCrossRefPubMed DeBoer MD, Gurka MJ: Low sensitivity for the metabolic syndrome to detect uric acid elevations in females and non-Hispanic-black male adolescents: An analysis of NHANES 1999–2006. Atherosclerosis. 2012, 220 (2): 575-580. 10.1016/j.atherosclerosis.2011.11.033.PubMedCentralCrossRefPubMed
31.
go back to reference DeBoer MD: Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention. Expert Rev Endocrinol Metab. 2011, 6 (2): 279-289. 10.1586/eem.11.17.PubMedCentralCrossRefPubMed DeBoer MD: Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention. Expert Rev Endocrinol Metab. 2011, 6 (2): 279-289. 10.1586/eem.11.17.PubMedCentralCrossRefPubMed
32.
go back to reference Sumner AE, Cowie CC: Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis. 2008, 196 (2): 696-703. 10.1016/j.atherosclerosis.2006.12.018.CrossRefPubMed Sumner AE, Cowie CC: Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis. 2008, 196 (2): 696-703. 10.1016/j.atherosclerosis.2006.12.018.CrossRefPubMed
33.
34.
go back to reference Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American diabetes association and the European association for the study of diabetes. Diabetes Care. 2005, 28 (9): 2289-2304. 10.2337/diacare.28.9.2289.CrossRefPubMed Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American diabetes association and the European association for the study of diabetes. Diabetes Care. 2005, 28 (9): 2289-2304. 10.2337/diacare.28.9.2289.CrossRefPubMed
35.
go back to reference Hong TK, Trang NH, Dibley MJ: Prevalence of metabolic syndrome and factor analysis of cardiovascular risk clustering among adolescents in Ho Chi minh city, Vietnam. Prev Med. 2012, E-pub ahead of print Hong TK, Trang NH, Dibley MJ: Prevalence of metabolic syndrome and factor analysis of cardiovascular risk clustering among adolescents in Ho Chi minh city, Vietnam. Prev Med. 2012, E-pub ahead of print
36.
go back to reference Defronzo RA: Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009, 58 (4): 773-795. 10.2337/db09-9028.PubMedCentralCrossRefPubMed Defronzo RA: Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009, 58 (4): 773-795. 10.2337/db09-9028.PubMedCentralCrossRefPubMed
37.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
38.
go back to reference Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation. 2004, 109 (3): 433-438. 10.1161/01.CIR.0000111245.75752.C6.CrossRefPubMed Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation. 2004, 109 (3): 433-438. 10.1161/01.CIR.0000111245.75752.C6.CrossRefPubMed
39.
go back to reference Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, et al: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004, 350 (23): 2362-2374. 10.1056/NEJMoa031049.CrossRefPubMed Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, et al: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004, 350 (23): 2362-2374. 10.1056/NEJMoa031049.CrossRefPubMed
41.
go back to reference Bosy-Westphal A, Booke CA, Blocker T, Kossel E, Goele K, Later W, Hitze B, Heller M, Gluer CC, Muller MJ: Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population. J Nutr. 2010, 140 (5): 954-961. 10.3945/jn.109.118737.CrossRefPubMed Bosy-Westphal A, Booke CA, Blocker T, Kossel E, Goele K, Later W, Hitze B, Heller M, Gluer CC, Muller MJ: Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population. J Nutr. 2010, 140 (5): 954-961. 10.3945/jn.109.118737.CrossRefPubMed
42.
go back to reference Freedman DS, Sherry B: The validity of BMI as an indicator of body fatness and risk among children. Pediatrics. 2009, 124 (Suppl 1): S23-34.CrossRefPubMed Freedman DS, Sherry B: The validity of BMI as an indicator of body fatness and risk among children. Pediatrics. 2009, 124 (Suppl 1): S23-34.CrossRefPubMed
43.
go back to reference Kannel WB: Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol. 2000, 85 (2): 251-255. 10.1016/S0002-9149(99)00635-9.CrossRefPubMed Kannel WB: Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol. 2000, 85 (2): 251-255. 10.1016/S0002-9149(99)00635-9.CrossRefPubMed
44.
go back to reference Yaun KH, Bentler PM: On Chi-square difference and Z-tests in mean and covariance structure analysis when the base model is misspecified. Educ Psychol Meas. 2004, 64: 737-757. 10.1177/0013164404264853.CrossRef Yaun KH, Bentler PM: On Chi-square difference and Z-tests in mean and covariance structure analysis when the base model is misspecified. Educ Psychol Meas. 2004, 64: 737-757. 10.1177/0013164404264853.CrossRef
45.
go back to reference Hu LT, Bentler PM: Cut-off criteria for fit indexes in covariance structure analysis: conventional criteria vs. new alternatives. Struct Equ Model. 1999, 6: 1-55. 10.1080/10705519909540118.CrossRef Hu LT, Bentler PM: Cut-off criteria for fit indexes in covariance structure analysis: conventional criteria vs. new alternatives. Struct Equ Model. 1999, 6: 1-55. 10.1080/10705519909540118.CrossRef
46.
go back to reference Kahn R: Metabolic syndrome: is it a syndrome? Does it matter?. Circulation. 2007, 115 (13): 1806-1810. 10.1161/CIRCULATIONAHA.106.658336. discussion 1811CrossRefPubMed Kahn R: Metabolic syndrome: is it a syndrome? Does it matter?. Circulation. 2007, 115 (13): 1806-1810. 10.1161/CIRCULATIONAHA.106.658336. discussion 1811CrossRefPubMed
47.
go back to reference Standards of medical care in diabetes. Diabetes Care. 2012, 35 (Suppl 1): S11-63. Standards of medical care in diabetes. Diabetes Care. 2012, 35 (Suppl 1): S11-63.
48.
go back to reference Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001, 7 (8): 941-946. 10.1038/90984.CrossRefPubMed Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001, 7 (8): 941-946. 10.1038/90984.CrossRefPubMed
49.
go back to reference Davidson MH: Apolipoprotein measurements: is more widespread use clinically indicated?. Clin Cardiol. 2009, 32 (9): 482-486. 10.1002/clc.20559.CrossRefPubMed Davidson MH: Apolipoprotein measurements: is more widespread use clinically indicated?. Clin Cardiol. 2009, 32 (9): 482-486. 10.1002/clc.20559.CrossRefPubMed
Metadata
Title
A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences
Authors
Matthew J Gurka
Christa L Ice
Shumei S Sun
Mark D DeBoer
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-128

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue